Stocks / Pharmaceuticals
RAREPharmaceuticals
Ultragenyx Pharmaceutical Inc.
$14.871d +14.6%5d +4.4%settled close · 2026-09-17
Mkt cap $1.8B (3/25)β 2.1352w $12.98–36Shares 96.6MInd. Pharmaceutical PreparationsNasdaq since 2014Emp. 1,371HQ Novato, CAultragenyx.com
Who’s talkingIdea Scout · free
Who’s talking about RARE
No tracked investor commentary on RARE yet — the corpus grows weekly.
Idea Scout tracks who’s
talking across television, podcasts, and interviews — every stance
dated to the appearance it came from.
Sign up free →
Earnings
Next report: 2 Nov 2026
Confirmed date · consensus EPS -1.02. Reactions below are the next settled session over the prior close.
The options tapeThe Brief · paid
Notable options days
Sessions in the last 120 where RARE’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 23 of 120 sessions qualified.
The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
| Date | Close | RVOL | Δ$ flow ($M) | Call % | LEAPS % | +20 sess. |
|---|---|---|---|---|---|---|
| 2026-09-17 | ||||||
| 2026-09-10 | ||||||
| 2026-09-04 | ||||||
| 2026-09-03 | ||||||
| 2026-08-26 | ||||||
| 2026-08-07 | ||||||
| 2026-08-06 | ||||||
| 2026-08-05 | ||||||
| 2026-07-23 | ||||||
| 2026-07-22 | ||||||
| 2026-07-20 | ||||||
| 2026-07-09 | ||||||
| 2026-07-08 | ||||||
| 2026-07-07 | ||||||
| 2026-07-06 | ||||||
| 2026-07-01 | ||||||
| 2026-06-25 | ||||||
| 2026-06-18 | ||||||
| 2026-06-17 | ||||||
| 2026-06-15 | ||||||
| 2026-06-12 | ||||||
| 2026-06-01 | ||||||
| 2026-05-18 |
+20 sess. = raw price change over the following 20
sessions — not market-adjusted; the tape tells you where to look,
not what happens next.
Today’s tape on
RARE is in this morning’s Brief.
Get The Brief — $20/mo →